Dr. Adam Cuker, MD

Dr. Cuker practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Cuker's NPI, 1457414625, was assigned on December 19, 2006. Dr. Cuker graduated from Yale University School of Medicine in 2003. Dr. Cuker holds Pennsylvania license MD429174.

Dr. Cuker's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Cuker's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Cuker is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Cuker to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cuker practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cuker's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Cuker is licensed in Pennsylvania.

CMS data shows 238 Medicare services from Dr. Cuker across 5 procedure codes in 2024, for 192 Medicare patients. Medicare paid $12,615 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Cuker in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cuker's median patient age at 51, with 59% women.

In 2024, Dr. Cuker wrote 532 Medicare Part D claims for 87 patients. 39% of them were for generic drugs. CMS names the drug for 468 of them, across 14 drugs with 11 or more claims each, at $1,261,238 in total drug cost. In 2023, CMS named 411 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Cuker for performance year 2024, reported as part of a group. Dr. Cuker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cuker as offering telehealth.

Dmand AI links 224 papers to Dr. Cuker, published from 2008 to 2025. 2021 was the busiest year, with 19. The most frequent topics are Anticoagulants, Thrombocytopenia and Hemorrhage. Dr. Cuker has published most often in Blood Adv. Dr. Cuker's most frequent co-authors are Allyson Marie Pishko, Reem A. Mustafa, MD and Elie Akl, MD.

Dmand AI links Dr. Cuker to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Coagulation Protein Disorders, Hemophilia A and Multiple Sclerosis, Relapsing-Remitting. American Thrombosis and Hemostasis Network sponsors the most, 3. Open Payments lists research payments to Dr. Cuker that name 1 trial.

CMS Open Payments shows 37 general payments to Dr. Cuker from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. CSL Behring paid the most, $30,593. It also lists 40 research payments totaling $60,077 from 2016 to 2025, naming 1 clinical trial.

Dr. Cuker graduated from Yale University School of Medicine in 2003.